文献速递免疫规划传染病防控与疫情报告

儿童年龄与肺炎球菌疫苗覆盖率呈非线性关系:对疫苗预防策略的重要启示

Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies.
PubMed 文献 · Vaccine · 2021-01-30

本研究分析儿童肺炎链球菌分离株的耐药、毒力基因、血清型和序列型,用限制性立方样条模型揭示年龄与疫苗覆盖率的关系。发现PCV13覆盖率为85.8%,年龄与PCV7/10/13覆盖率呈显著非线性关系,<2岁儿童波动明显;蛋白候选疫苗ply和lytA在各年龄组覆盖率高且稳定,并揭示表型-基因型高维对应关系。

要点

  • PCV13总体覆盖率为85.8%,年龄与PCV7/10/13覆盖率呈非线性关系。
  • PCV高覆盖年龄为≥2岁,<2岁儿童覆盖率波动明显。
  • ply和lytA在各年龄组保持稳定高覆盖率,可作为新一代蛋白疫苗优先候选靶点。

核心结论

  • 儿童年龄与肺炎球菌疫苗覆盖率呈显著非线性关系,PCV高覆盖年龄为≥2岁。
  • ply和lytA在各年龄组覆盖率高且稳定,支持其作为新一代蛋白疫苗优先候选靶点。

研究设计与样本

  • 基于儿童肺炎链球菌分离株,检测抗菌药物敏感性、毒力基因、血清型和序列型。
  • 采用限制性立方样条模型分析儿童年龄与疫苗覆盖率的关系。

主要发现

  • PCV13覆盖率为85.8%,年龄与PCV7、PCV10和PCV13覆盖率呈显著非线性关系,<2岁儿童波动明显。
  • 蛋白和菌毛候选疫苗覆盖率与年龄呈动态非线性关系,ply和lytA在所有年龄组保持稳定高覆盖率。
  • 肺炎链球菌分离株的表型-基因型特征间存在显著高维对应关系,如ST271与血清型19F、PI-2及广泛耐药相关。

关键数值与推荐

  • PCV13覆盖率为85.8%。
  • PCV高覆盖年龄为儿童≥2岁。
  • ply和lytA在所有年龄组保持稳定高覆盖率。

临床怎么用

  • 针对≥2岁儿童可维持PCV高覆盖率,<2岁儿童需关注覆盖率波动并优化免疫策略。
  • ply和lytA可作为新一代蛋白疫苗开发的优先候选靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Streptococcus pneumoniae (S. pneumoniae) is an important pathogen causing both invasive and non-invasive infections in children, with significant morbidity and mortality worldwide. This study aimed to determine the potential relationships between age and vaccine coverage and between multiple phenotype-genotype characteristics of S. pneumoniae isolated from children. METHODS: All S. pneumoniae isolates were tested for antimicrobial susceptibility, virulence genes, serotypes, and sequence types. The restricted cubic spline models were used to reveal potential relationships between children age and pneumococcal vaccine coverage. RESULTS: For capsular-based vaccines, we observed a high coverage rate of 13-valent pneumococcal conjugate vaccine (PCV13, 85.8%) and a significantly non-linear relationship between children age and vaccine coverage (including PCV7, PCV10, and PCV13), with marked fluctuations in children aged < 2 years. For protein-based and pilus-based vaccine candidates, we demonstrated dynamic non-linear relationships between age and vaccine coverage, maintaining a stable and high coverage rate of ply and lytA for all age groups. Moreover, there were significantly high-dimensional corresponding relationships among multiple phenotype-genotype characteristics of S. pneumoniae isolates (such as ST271 associated with serotype 19F, PI-2, and extensively drug-resistance). CONCLUSIONS: Our findings suggest that the age for high PCV coverage being children aged ≥ 2 years and also provide important evidence for supporting ply and lytA as priority candidate targets for the development of new-generation protein vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu Y, Li W, Dong Q, et al. Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies. Vaccine. 2021. PMID: 33531198. doi:10.1016/j.vaccine.2021.01.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。